![]() |
Genimous Technology Co., Ltd. (000676.SZ) DCF Valuation
CN | Technology | Information Technology Services | SHZ
|

- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Genimous Technology Co., Ltd. (000676.SZ) Bundle
Enhance your investment strategies with the (000676SZ) DCF Calculator! Explore genuine financial data from Genimous Technology Co., Ltd., adjust growth projections and expenses, and instantly observe how these modifications affect the intrinsic value of [Symbol].
Discounted Cash Flow (DCF) - (USD MM)
Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | 10,873.7 | 10,778.5 | 5,844.3 | 2,728.5 | 2,928.8 | 2,250.6 | 1,729.4 | 1,328.9 | 1,021.2 | 784.7 |
Revenue Growth, % | 0 | -0.87601 | -45.78 | -53.31 | 7.34 | -23.16 | -23.16 | -23.16 | -23.16 | -23.16 |
EBITDA | 756.2 | -2,837.3 | 181.3 | -337.8 | 414.4 | -65.3 | -50.1 | -38.5 | -29.6 | -22.8 |
EBITDA, % | 6.95 | -26.32 | 3.1 | -12.38 | 14.15 | -2.9 | -2.9 | -2.9 | -2.9 | -2.9 |
Depreciation | 69.7 | 58.3 | 49.2 | 37.4 | 32.9 | 20.3 | 15.6 | 12.0 | 9.2 | 7.1 |
Depreciation, % | 0.64111 | 0.5407 | 0.84255 | 1.37 | 1.12 | 0.90422 | 0.90422 | 0.90422 | 0.90422 | 0.90422 |
EBIT | 686.4 | -2,895.6 | 132.1 | -375.3 | 381.5 | -85.6 | -65.8 | -50.6 | -38.8 | -29.8 |
EBIT, % | 6.31 | -26.86 | 2.26 | -13.75 | 13.02 | -3.8 | -3.8 | -3.8 | -3.8 | -3.8 |
Total Cash | 1,521.5 | 1,174.5 | 998.3 | 1,499.4 | 1,438.0 | 657.3 | 505.1 | 388.1 | 298.2 | 229.2 |
Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables | 2,364.6 | 1,641.0 | 1,114.7 | 788.4 | 740.8 | 496.2 | 381.3 | 293.0 | 225.1 | 173.0 |
Account Receivables, % | 21.75 | 15.22 | 19.07 | 28.89 | 25.29 | 22.05 | 22.05 | 22.05 | 22.05 | 22.05 |
Inventories | .4 | 1.4 | 43.9 | 34.1 | 37.9 | 14.9 | 11.5 | 8.8 | 6.8 | 5.2 |
Inventories, % | 0.00408172 | 0.01272777 | 0.75133 | 1.25 | 1.29 | 0.66217 | 0.66217 | 0.66217 | 0.66217 | 0.66217 |
Accounts Payable | 1,062.6 | 759.7 | 270.9 | 349.3 | 203.7 | 185.5 | 142.5 | 109.5 | 84.2 | 64.7 |
Accounts Payable, % | 9.77 | 7.05 | 4.64 | 12.8 | 6.96 | 8.24 | 8.24 | 8.24 | 8.24 | 8.24 |
Capital Expenditure | -13.7 | -10.1 | -101.3 | -18.0 | -13.1 | -13.8 | -10.6 | -8.1 | -6.3 | -4.8 |
Capital Expenditure, % | -0.1258 | -0.09364895 | -1.73 | -0.65984 | -0.44869 | -0.61237 | -0.61237 | -0.61237 | -0.61237 | -0.61237 |
Tax Rate, % | 22.12 | 22.12 | 22.12 | 22.12 | 22.12 | 22.12 | 22.12 | 22.12 | 22.12 | 22.12 |
EBITAT | 640.9 | -2,918.5 | 153.1 | -413.8 | 297.1 | -80.7 | -62.0 | -47.6 | -36.6 | -28.1 |
Depreciation | ||||||||||
Changes in Account Receivables | ||||||||||
Changes in Inventories | ||||||||||
Changes in Accounts Payable | ||||||||||
Capital Expenditure | ||||||||||
UFCF | -605.4 | -2,450.6 | 96.0 | 20.1 | 215.1 | 175.3 | 18.4 | 14.2 | 10.9 | 8.4 |
WACC, % | 6.98 | 6.98 | 6.98 | 6.98 | 6.96 | 6.98 | 6.98 | 6.98 | 6.98 | 6.98 |
PV UFCF | ||||||||||
SUM PV UFCF | 205.8 | |||||||||
Long Term Growth Rate, % | 4.00 | |||||||||
Free cash flow (T + 1) | 9 | |||||||||
Terminal Value | 292 | |||||||||
Present Terminal Value | 209 | |||||||||
Enterprise Value | 414 | |||||||||
Net Debt | -683 | |||||||||
Equity Value | 1,098 | |||||||||
Diluted Shares Outstanding, MM | 1,265 | |||||||||
Equity Value Per Share | 0.87 |
What You Will Receive
- Pre-Loaded Financial Model: Genimous Technology’s real data facilitates accurate DCF valuation.
- Complete Forecast Control: Modify revenue growth, margins, WACC, and other essential factors.
- Real-Time Calculations: Automatic updates allow you to see results immediately as you adjust inputs.
- Professional-Grade Template: A polished Excel file crafted for serious valuation needs.
- Adaptable and Reusable: Designed for flexibility, allowing repeated use for in-depth forecasts.
Key Features
- Comprehensive DCF Calculator: Features detailed unlevered and levered DCF valuation models tailored for Genimous Technology Co., Ltd. (000676SZ).
- WACC Estimator: Includes a pre-constructed Weighted Average Cost of Capital sheet with adjustable inputs to fit your analysis.
- Customizable Forecast Assumptions: Easily change growth rates, capital expenditures, and discount rates to suit your projections.
- Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios specific to Genimous Technology Co., Ltd. (000676SZ).
- User-Friendly Dashboard and Charts: Visual representations that summarize essential valuation metrics for streamlined analysis.
How It Functions
- Step 1: Obtain the prebuilt Excel template featuring Genimous Technology's data.
- Step 2: Review the filled-in sheets to familiarize yourself with the essential metrics.
- Step 3: Modify forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
- Step 4: Instantly access recalibrated results, including Genimous Technology's intrinsic value.
- Step 5: Utilize the outputs to make informed investment choices or create detailed reports.
Why Choose Genimous Technology Co., Ltd. ([000676SZ]) Calculator?
- All-in-One Solution: Features DCF, WACC, and comprehensive financial ratio analyses seamlessly integrated.
- Flexible Customization: Modify the cells highlighted in yellow to explore different financial scenarios.
- In-Depth Analysis: Automatically computes the intrinsic value and Net Present Value for Genimous Technology.
- Built-In Data: Includes a robust dataset of historical and projected figures for reliable baseline assessments.
- Professional Standard: Perfectly suited for financial analysts, investors, and business advisors.
Who Can Benefit from Genimous Technology Co., Ltd. ([000676SZ])?
- Individual Investors: Gain insights to make well-informed decisions on buying or selling shares of Genimous Technology Co., Ltd. ([000676SZ]).
- Financial Analysts: Enhance your valuation processes with easy-to-use financial models tailored for Genimous Technology Co., Ltd. ([000676SZ]).
- Consultants: Provide clients with accurate and timely valuation insights related to Genimous Technology Co., Ltd. ([000676SZ]).
- Business Owners: Learn how the valuation of a tech company like Genimous Technology Co., Ltd. ([000676SZ]) can inform your own business strategies.
- Finance Students: Study valuation techniques using real-world data and practical examples from Genimous Technology Co., Ltd. ([000676SZ]).
Overview of the Template's Contents
- Pre-Filled Data: Contains Genimous Technology Co., Ltd.'s historical financial performance and forecasts.
- Discounted Cash Flow Model: An interactive DCF valuation model featuring automatic calculations.
- Weighted Average Cost of Capital (WACC): A dedicated worksheet for calculating WACC based on user-defined inputs.
- Key Financial Ratios: Assess Genimous's profitability, operational efficiency, and capital structure.
- Customizable Inputs: Easily modify revenue growth rates, profit margins, and tax percentages.
- User-Friendly Dashboard: Visual representations and tables highlighting essential valuation outcomes.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.